Biotech companies may benefit from new rules


The biotechnology industry may benefit from new European rules that allow governments to give extra incentives to young innovative companies, said a trade group representing companies including Syngenta AG.

The new European Union rules allow member states to give public funds and tax incentives to companies that are less than 6 years old and spend at least 15% of their sales on research and development, the Brussels-based European Association for Bioindustries said in an e-mailed statement yesterday. The average cost of developing a new biotechnology product is about $1.2 billion, according to an estimate by the Boston- based Tufts Center for the Study of Drug Development. The new European rules will take effect from January 1, EuropaBio said. “This measure will help young innovative companies to become more attractive to investors and play their full role in building the knowledge based bio-economy, creating jobs and growth,” Johan Vanhemelrijck, EuropaBio's secretary general, said in the statement. The new rules also recognize EuropaBio's Young Innovative Companies status as an eligibility criterion for state aid, the trade group said. Governments can provide the incentives without running into trouble with EU competition rules, EuropaBio said. (Bloomberg)


Business, consumer confidence slip in May Analysis

Business, consumer confidence slip in May

Parl't elects Orbán prime minister Parliament

Parl't elects Orbán prime minister

New managing director at LG Electronics Hungary Appointments

New managing director at LG Electronics Hungary

Airport bus fare could rise to HUF 1,500 City

Airport bus fare could rise to HUF 1,500


Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.